January 2025

NEWS & COLUMNS

6-7 NEWS
Novartis and PTC in $2.9bn Huntington’s deal; AstraZeneca’s Tagrisso approved by EC

8-9 NEWS
AbbVie’s Parkinson’s drug shows promise in phase 3 trial; Eli Lilly announces $3bn US expansion

10-11 DERMATOLOGY NEWS
FDA approves Organon’s Vtama; J&J expands atopic dermatitis pipeline with Kaken deal

12 DARWIN'S MEDICINE
Good strategists are good for other things too

13 BACK TO WORK
Supporting individuals when they return to work after an extended absence

14 INNOVATIVE IMPACT
Shaping the future of pharma with human-centric transformation techniques

15 THE POWER OF COLLABORATION
How partnerships in the pharma industry have become a cornerstone of progress

FEATURES

16-18 THE POWER OF PURPOSE
Iona Everson from PMGroup speaks to Amar Urhekar, CEO of Avalere Health, about his professional journey within healthcare marketing and his commitment to building unconventional solutions that reach patients where they are

19-21 CREATING AND SUSTAINING UNIVERSITY BIOTECH SPIN-OUTS
Part 1: Driving the future economy

22-23 THE SILENT TREATMENT – RESEARCHING GENE SILENCING FOR ALZHEIMER’S, PARKINSON’S AND MOTOR NEURONE DISEASE
The science behind gene-silencing technology and the barriers and challenges faced by drug developers

24-26 INSIGHTS FROM ASH 2024
With a menu featuring everything from cutting-edge science to DEI and diet, ASH 2024 certainly offered congress attendees food for thought